Esketamine does of 56 and 84 mg with comprehensive standard-of-care rapidly improved depressive symptoms in adolescents at risk for suicide.

More information: Antonio Del Casale et al, Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression, JAMA Psychiatry (2025). DOI: 10.1001/jamapsychiatry.2025.0200 ...

Unlike older medications that target serotonin – a “feel-good” chemical in the brain – the ketamine-based nasal spray works ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...

A new nasal spray treatment for depression has been added to the Pharmaceutical Benefits Scheme. The drug called esketamine ...

A new nasal spray, that’s chemically similar to Ketamine, is being added to the Pharmaceutical Benefits Scheme, for adults ...

Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) for treatment-resistant depression (TRD) was linked to significantly lower rates of several adverse outcomes than ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...

A new drug for treatment-resistant depression will be listed on the Pharmaceutical Benefits Scheme this week, making it more ...

Recent randomized clinical trial was conducted to evaluate the efficacy of intraoperative esketamine in reducing postpartum ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...